摘要
2016年,我国仿制药质量与疗效一致性评价进入政策密集推动期,标志着我国一致性评价正式步入实施阶段。本文旨在探讨仿制药一致性评价与药品集中采购的内在关联性及其发展趋势,分析仿制药一致性评价对我国药品集中采购竞价分组影响机制,探索我国药品集中采购政策发展路径。
In 2016, Generics Quality Consistency Evaluation entered a period of intensive policies, which marked the evaluation work in China formally entered implementation stage. Our aim is to discuss inter-connection between Generics Quality Consistency Evaluation System and Centralized Drug Procurement System as well as future trends. Meanwhile, we will analyze the influencing mechanism of Generics Quality Consistency Evaluation on bidding and grouping method of Centralized Drug Procurement System in China, thus to explore the development path of China's centralized drug purchasing policy.
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
2017年第4期605-613,共9页
Chinese Journal of Pharmaceuticals
关键词
仿制药一致性评价
药品集中采购
竞价分组
Generics Quality Consistency Evaluation
Centralized Drug Procurement
bidding and grouping method